Back to results
US 2006/0153778 A1Published application
Methods and compositions for minimizing accrual of inhalable insulin in the lungs
AssigneeMannKind Corporation
InventorsCohava Gelber, Anders Boss
Life of this patent
Estimating the term…
Abstract
Inhalable insulin compositions are provided that rapidly clear from the lungs of patients. Additionally, methods of minimizing insulin accrual after administration of an inhaled insulin composition are disclosed.
Claims17
A method for minimizing insulin accrual in the lungs of a patient after the administration of an inhaled insulin comprising:
- providing said inhalable insulin composition to a patient in need thereof;
- administering said inhalable insulin composition to said patient's lungs;
- wherein said administering is performed via inhalation;
- and
- wherein said inhaled insulin is cleared from said patient's lungs in less than approximately six hours
2 more elements
An inhalable insulin composition comprising:
- an insulin/diketopiperazine complex wherein said insulin is cleared from a patient's lungs in less than approximately six hours after inhalation.
A method of treating diabetes comprising
- providing an inhalable insulin composition to a patient in need thereof wherein extended use of said inhalable insulin composition does not impair lung function.
An inhalable insulin composition useful for treating diabetes comprising:
- an insulin/diketopiperazine complex wherein said inhalable insulin composition does not impair lung function.
Dependencies are inferred from the claim text.